Patient | Age at diagnosis | Germline mutation | Stage | Neoadjuvant chemotherapy | Surgery outcome | Concurrent endometriosis |
1 | 69 | Negative | IVB | No | OD | No |
2 | 58 | Negative | IIA | No | CGR | No |
3 | 34 | Negative | IIIC | Yes | SD | Yes |
4 | 67 | – | IC | No | OD | No |
5 | 63 | PMS2 | IIIA1 | No | CGR | Yes |
6 | 53 | Negative | IVB | No | OD | Yes |
7 | 50 | Negative | IIIC | No | OD | Yes |
8 | 38 | Negative | IVB | Yes | CGR | Yes |
9 | 49 | SDHA | IIIA2 | No | CGR | Yes |
10 | 47 | Negative | IIIB | No | OD | Yes |
11 | 54 | BRCA1 | IVB | No | SD | No |
12 | 62 | Negative | IIIC | Yes | OD | No |
13 | 48 | – | IC | No | – | No |
14 | 58 | – | IIIB | No | – | Yes |
15 | 42 | – | IV | Yes | – | No |
16 | 47 | – | IIIA | No | CGR | Yes |
OD, optimal debulking; CGR, complete gross resection; SD, suboptimal debulking